Stericycle Company Profile (NASDAQ:SRCL)

About Stericycle (NASDAQ:SRCL)

Stericycle logoStericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company's segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.

Industry, Sector and Symbol:
  • Sector: Business Services
  • Industry: Waste Management, Disposal & Recycling Services
  • Sub-Industry: Environmental & Facilities Services
  • Symbol: NASDAQ:SRCL
  • CUSIP: 85891210
  • Web:
  • Market Cap: $6.08 billion
  • Outstanding Shares: 85,338,000
Average Prices:
  • 50 Day Moving Avg: $71.20
  • 200 Day Moving Avg: $77.45
  • 52 Week Range: $68.62 - $88.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 14.91
  • P/E Growth: 2.04
Sales & Book Value:
  • Annual Revenue: $3.61 billion
  • Price / Sales: 1.68
  • Book Value: $32.22 per share
  • Price / Book: 2.21
  • EBITDA: $777.58 million
  • Net Margins: -0.07%
  • Return on Equity: 14.35%
  • Return on Assets: 5.79%
  • Debt-to-Equity Ratio: 1.00%
  • Current Ratio: 0.87%
  • Quick Ratio: 0.87%
  • Average Volume: 739,688 shs.
  • Beta: 0.15
  • Short Ratio: 7.64

Frequently Asked Questions for Stericycle (NASDAQ:SRCL)

What is Stericycle's stock symbol?

Stericycle trades on the NASDAQ under the ticker symbol "SRCL."

How were Stericycle's earnings last quarter?

Stericycle, Inc. (NASDAQ:SRCL) released its earnings results on Thursday, August, 3rd. The company reported $1.15 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.13 by $0.02. The company had revenue of $917.70 million for the quarter, compared to analysts' expectations of $902.81 million. Stericycle had a positive return on equity of 14.35% and a negative net margin of 0.07%. The business's revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.18 EPS. View Stericycle's Earnings History.

When will Stericycle make its next earnings announcement?

Stericycle is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Stericycle.

Where is Stericycle's stock going? Where will Stericycle's stock price be in 2017?

12 analysts have issued 1 year target prices for Stericycle's shares. Their predictions range from $10.00 to $108.00. On average, they anticipate Stericycle's share price to reach $80.91 in the next twelve months. View Analyst Ratings for Stericycle.

What are analysts saying about Stericycle stock?

Here are some recent quotes from research analysts about Stericycle stock:

  • 1. According to Zacks Investment Research, "Stericycle’s acquisition binge is leading to higher overheads and integration-related expenses, which are weighing on margins. Furthermore, many acquisitions have lower gross margins and higher selling, general and administrative expenses that often negate the positives. In addition, low barriers to entry in the industry and stiff competition from local as well as global players significantly reduce its price control. High operating costs also continue to be a headwind for Stericycle. Moreover, a challenging macroeconomic environment and volatility in foreign exchange are affecting the profitability. Evolving rules and regulations impose new compliance requirements and further erode margins. Stericycle underperformed the industry year to date. However, Stericycle has a competitive edge with the largest collection and transportation network in the industry, which allows it to compete effectively on both service and price perspectives." (10/4/2017)
  • 2. Jefferies Group LLC analysts commented, "Even better than we were expecting and contrary to what was foreshadowed in the Jan 26 8-K, SRCL exceeded our 4Q EPS estimate by $0.05 (or 5%). The operational assumptions embedded in '17 guidance were also reaffirmed, though the mid-point of the range is $0.03 (or 1%) lower on a stronger FX headwind. Notably, the pricing resets are tracking as expected and the early pilot programs aimed at mitigating drag from future renewals are showing encouraging results." (2/16/2017)

Who are some of Stericycle's key competitors?

Who are Stericycle's key executives?

Stericycle's management team includes the folowing people:

  • Mark C. Miller, Chairman of the Board
  • Charles A. Alutto, President, Chief Executive Officer, Director
  • Daniel V. Ginnetti, Chief Financial Officer, Executive Vice President
  • Brent Arnold, Chief Operating Officer, Executive Vice President
  • John P. Schetz, Executive Vice President, General Counsel
  • Ruth-Ellen Abdulmassih, Executive Vice President and President, Communication & Related Services
  • Michael J. Collins, Executive Vice President, President - Recall and Returns Management Services
  • Brenda Frank, Executive Vice President, Chief People Officer
  • Richard J. Hoffman, Senior Vice President, Chief Accounting Officer
  • Jack W. Schuler, Lead Independent Director

Who owns Stericycle stock?

Stericycle's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Eqis Capital Management Inc. (0.01%) and Fulton Bank N.A. (0.01%). Company insiders that own Stericycle stock include Daniel Ginnetti, John P Schetz, Mark C Miller, Mike S Zafirovski, Robert S Murley and Rodney F Dammeyer. View Institutional Ownership Trends for Stericycle.

Who sold Stericycle stock? Who is selling Stericycle stock?

Stericycle's stock was sold by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. View Insider Buying and Selling for Stericycle.

Who bought Stericycle stock? Who is buying Stericycle stock?

Stericycle's stock was purchased by a variety of institutional investors in the last quarter, including Fulton Bank N.A.. Company insiders that have bought Stericycle stock in the last two years include Mike S Zafirovski and Robert S Murley. View Insider Buying and Selling for Stericycle.

How do I buy Stericycle stock?

Shares of Stericycle can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Stericycle's stock price today?

One share of Stericycle stock can currently be purchased for approximately $71.27.

MarketBeat Community Rating for Stericycle (NASDAQ SRCL)
Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  258 (Vote Outperform)
Underperform Votes:  320 (Vote Underperform)
Total Votes:  578
MarketBeat's community ratings are surveys of what our community members think about Stericycle and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Stericycle (NASDAQ:SRCL) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 4 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $80.91 (13.52% upside)
Consensus Price Target History for Stericycle (NASDAQ:SRCL)
Price Target History for Stericycle (NASDAQ:SRCL)
Analysts' Ratings History for Stericycle (NASDAQ:SRCL)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/14/2017William BlairReiterated RatingOurperformLowView Rating Details
8/11/2017Jefferies Group LLCSet Price TargetBuy$108.00N/AView Rating Details
8/9/2017Barclays PLCReiterated RatingOverweight$100.00LowView Rating Details
6/29/2017BMO Capital MarketsInitiated CoverageMarket Perform$81.00LowView Rating Details
5/15/2017Robert W. BairdDowngradeNeutral -> Underperform$74.00 -> $73.00LowView Rating Details
5/15/2017Deutsche Bank AGLower Price TargetBuy$14.00 -> $10.00LowView Rating Details
3/7/2017Goldman Sachs Group, Inc. (The)UpgradeSell -> Neutral$62.00 -> $79.00N/AView Rating Details
2/22/2017Barrington ResearchBoost Price TargetOutperform -> Outperform$84.00 -> $93.00N/AView Rating Details
2/20/2017Raymond James Financial, Inc.Reiterated RatingMarket PerformN/AView Rating Details
2/6/2017MacquarieSet Price TargetBuy$100.00N/AView Rating Details
2/6/2017Stifel NicolausSet Price TargetBuy$90.00N/AView Rating Details
1/21/2017Royal Bank Of CanadaSet Price TargetSell$74.00N/AView Rating Details
11/15/2016WedbushReiterated RatingNeutral$85.00 -> $82.00N/AView Rating Details
9/20/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
9/9/2016Imperial CapitalLower Price TargetUnderperform$93.50 -> $80.00N/AView Rating Details
7/29/2016Wellington ShieldsDowngradeAccumulate -> HoldN/AView Rating Details
4/30/2016Oppenheimer Holdings, Inc.Reiterated RatingHoldN/AView Rating Details
3/22/2016Sterne Agee CRTInitiated CoverageBuy$151.00N/AView Rating Details
(Data available from 10/17/2015 forward)


Earnings History for Stericycle (NASDAQ:SRCL)
Earnings by Quarter for Stericycle (NASDAQ:SRCL)
Earnings History by Quarter for Stericycle (NASDAQ SRCL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017$1.15N/AView Earnings Details
8/3/2017Q2 2017$1.13$1.15$902.81 million$917.70 millionViewListenView Earnings Details
5/4/2017Q1 2017$1.05$1.09$874.34 million$892.40 millionViewListenView Earnings Details
2/15/2017Q416$0.93$1.00$902.62 million$906.40 millionViewListenView Earnings Details
10/27/2016Q316$1.17$1.24$899.87 million$890.10 millionViewListenView Earnings Details
7/28/2016Q216$1.18$1.18$910.29 million$891.60 millionViewListenView Earnings Details
4/28/2016Q116$1.15$1.11$871.54 million$874.20 millionViewListenView Earnings Details
2/4/2016Q415$1.10$1.11$900.85 million$888.30 millionViewN/AView Earnings Details
10/22/2015Q3$1.19$1.08$735.47 million$718.60 millionViewListenView Earnings Details
7/23/2015Q2$1.14$1.14$702.84 million$715.70 millionViewListenView Earnings Details
4/23/2015Q115$1.10$1.08$676.43 million$663.30 millionViewListenView Earnings Details
2/5/2015Q414$1.12$1.12$685.25 million$676.90 millionViewListenView Earnings Details
10/23/2014Q3$1.06$1.08$662.93 million$667.90 millionViewListenView Earnings Details
7/24/2014Q2$1.03$1.03$633.95 million$640.80 millionViewListenView Earnings Details
4/24/2014Q1$0.99$1.04$572.41 million$570.00 millionViewListenView Earnings Details
2/5/2014Q4$0.96$0.99$566.15 million$567.90 millionViewListenView Earnings Details
10/23/2013Q313$0.94$0.96$542.38 million$534.60 millionViewListenView Earnings Details
7/24/2013Q2 2013$0.91$0.93$529.08 million$526.50 millionViewListenView Earnings Details
4/24/2013Q1 2013$0.88$0.88$519.58 million$513.80 millionViewListenView Earnings Details
2/6/2013Q4 2012$0.86$0.88$491.37 million$503.63 millionViewListenView Earnings Details
10/24/2012Q312$0.82$0.84$477.44 million$480.50 millionViewN/AView Earnings Details
7/25/2012$0.80$0.81ViewN/AView Earnings Details
4/25/2012$0.76$0.78ViewN/AView Earnings Details
2/2/2012$0.73$0.76ViewN/AView Earnings Details
10/26/2011$0.70$0.71ViewN/AView Earnings Details
7/27/2011$0.70$0.69ViewN/AView Earnings Details
4/27/2011$0.66$0.68ViewN/AView Earnings Details
2/3/2011$0.64$0.69ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Stericycle (NASDAQ:SRCL)
2017 EPS Consensus Estimate: $4.55
2018 EPS Consensus Estimate: $4.82
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20176$1.02$1.05$1.03
Q2 20176$1.10$1.19$1.13
Q3 20176$1.13$1.19$1.16
Q4 20176$1.20$1.29$1.23
Q1 20183$1.17$1.24$1.20
Q2 20183$1.07$1.22$1.16
Q3 20183$1.17$1.22$1.19
Q4 20183$1.23$1.32$1.28
(Data provided by Zacks Investment Research)


Dividend History for Stericycle (NASDAQ:SRCL)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Stericycle (NASDAQ:SRCL)
Insider Ownership Percentage: 3.30%
Institutional Ownership Percentage: 93.54%
Insider Trades by Quarter for Stericycle (NASDAQ:SRCL)
Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)
Insider Trades by Quarter for Stericycle (NASDAQ:SRCL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/23/2017Mike S ZafirovskiDirectorBuy2,920$85.67$250,156.40View SEC Filing  
2/1/2017Robert S MurleyDirectorBuy1,000$76.22$76,220.00View SEC Filing  
12/13/2016Mark C MillerDirectorSell6,677$76.23$508,987.71View SEC Filing  
9/14/2016John P SchetzEVPSell1,398$81.85$114,426.30View SEC Filing  
8/17/2016Rodney F DammeyerDirectorSell10,188$85.50$871,074.00View SEC Filing  
7/8/2016Mark C MillerDirectorSell34,835$104.52$3,640,954.20View SEC Filing  
7/1/2016Mark C MillerDirectorSell24,665$104.55$2,578,725.75View SEC Filing  
6/15/2016Mark C MillerDirectorSell25,000$101.12$2,528,000.00View SEC Filing  
2/22/2016Daniel GinnettiCFOSell17,184$110.67$1,901,753.28View SEC Filing  
12/11/2015John P. SchetzEVPSell1,190$116.34$138,444.60View SEC Filing  
8/18/2015Rodney F DammeyerDirectorSell8,500$147.44$1,253,240.00View SEC Filing  
6/3/2015John P SchetzInsiderSell2,150$137.47$295,560.50View SEC Filing  
2/20/2015Michael J CollinsEVPSell25,000$133.87$3,346,750.00View SEC Filing  
2/17/2015Brent ArnoldCOOSell4,000$132.91$531,640.00View SEC Filing  
2/17/2015Daniel GinnettiCFOSell5,000$132.86$664,300.00View SEC Filing  
2/12/2015Charles A AluttoCEOSell9,000$132.02$1,188,180.00View SEC Filing  
12/30/2014Rodney F DammeyerDirectorSell9,500$132.60$1,259,700.00View SEC Filing  
12/10/2014John PatienceDirectorSell65,124$130.75$8,514,963.00View SEC Filing  
10/31/2014Daniel GinnettiCFOSell5,000$125.05$625,250.00View SEC Filing  
10/30/2014Brent ArnoldEVPSell1,750$123.61$216,317.50View SEC Filing  
10/28/2014Richard T KoglerCOOSell26,437$123.51$3,265,233.87View SEC Filing  
10/27/2014Brent ArnoldEVPSell3,000$123.06$369,180.00View SEC Filing  
10/27/2014Mark C MillerChairmanSell40,000$122.61$4,904,400.00View SEC Filing  
10/27/2014Richard T KoglerCOOSell12,500$123.09$1,538,625.00View SEC Filing  
8/19/2014Charles A AluttoCEOSell16,500$119.33$1,968,945.00View SEC Filing  
7/29/2014Brink Frank Jm TenCFOSell45,000$118.84$5,347,800.00View SEC Filing  
7/29/2014Richard T KoglerCOOSell15,000$119.35$1,790,250.00View SEC Filing  
6/10/2014William K HallDirectorSell16,466$115.69$1,904,951.54View SEC Filing  
4/30/2014Brink Frank Jm TenCFOSell30,000$116.09$3,482,700.00View SEC Filing  
4/30/2014Richard KoglerCOOSell8,750$116.12$1,016,050.00View SEC Filing  
2/14/2014Brink Frank Jm TenCFOSell16,574$116.18$1,925,567.32View SEC Filing  
2/14/2014Richard KoglerCOOSell14,958$116.18$1,737,820.44View SEC Filing  
2/13/2014Rodney DammeyerDirectorSell20,000$115.76$2,315,200.00View SEC Filing  
2/12/2014Brink Frank Jm TenCFOSell10,202$116.04$1,183,840.08View SEC Filing  
2/12/2014Richard KoglerCOOSell9,608$116.04$1,114,912.32View SEC Filing  
12/20/2013Jack SchulerDirectorSell6,452$96.40$621,972.80View SEC Filing  
12/10/2013Mark MillerChairmanSell52,538$115.68$6,077,595.84View SEC Filing  
11/14/2013Mark MillerChairmanSell13,000$117.50$1,527,500.00View SEC Filing  
11/4/2013Brink Frank Jm TenCFOSell18,274$116.68$2,132,210.32View SEC Filing  
11/4/2013Richard T KoglerCOOSell9,002$116.65$1,050,083.30View SEC Filing  
8/1/2013Brink Frank Jm TenCFOSell45,859$116.35$5,335,694.65View SEC Filing  
8/1/2013Richard T KoglerCOOSell5,000$116.57$582,850.00View SEC Filing  
7/31/2013Michael J CollinsEVPSell30,119$116.25$3,501,333.75View SEC Filing  
7/30/2013Richard T KoglerCOOSell30,000$116.00$3,480,000.00View SEC Filing  
7/30/2013William K HallDirectorSell12,529$115.62$1,448,602.98View SEC Filing  
6/28/2013Jonathan T Md LordDirectorSell6,040$110.00$664,400.00View SEC Filing  
6/13/2013Jack W SchulerDirectorSell1,892$105.75$200,079.00View SEC Filing  
6/7/2013John PatienceDirectorSell45,500$108.20$4,923,100.00View SEC Filing  
8/8/2012Ronald G SpaethDirectorSell7,033$89.43$628,961.19View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Stericycle (NASDAQ:SRCL)
Latest Headlines for Stericycle (NASDAQ:SRCL)
DateHeadline logoETFs with exposure to Stericycle, Inc. : October 13, 2017 - October 14 at 8:08 AM logoPaved with Good Intentions: Most Car Owners Claim They Act on Recall Notices, But Compliance Data Suggests Far Fewer Do - October 12 at 9:48 AM logoStericycle Must Be Near A Bottom - Seeking Alpha - October 11 at 8:00 AM logoStericycle, Inc. (SRCL) Given Average Recommendation of "Hold" by Analysts - October 8 at 9:00 AM logoScott+Scott, Attorneys at Law, LLP Is Investigating Derivative Claims on Behalf of Shareholders of Stericycle, Inc. (SRCL) - October 6 at 12:25 PM logoStericycle, Inc. :SRCL-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 - October 3 at 12:53 PM logoStericycle, Inc. :SRCL-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 - October 3 at 12:53 PM logoETFs with exposure to Stericycle, Inc. : October 2, 2017 - October 3 at 12:53 PM logoETFs with exposure to Stericycle, Inc. : October 2, 2017 - October 3 at 12:53 PM logoStericycle, Inc. (SRCL) Expected to Post Quarterly Sales of $897.97 Million - October 1 at 3:22 PM logoFinancial Comparison: Marathon Patent Group (MARA) & Stericycle (SRCL) - September 30 at 6:26 AM logoStericycle to Participate in Barrington Research Conference in September - September 20 at 9:22 AM logoFY2017 EPS Estimates for Stericycle, Inc. (SRCL) Lowered by Analyst - September 18 at 2:38 AM logoStericycle, Inc. Expected to Post Q1 2018 Earnings of $1.17 Per Share (SRCL) - September 15 at 11:04 AM logoStericycle, Inc. (SRCL) Receives Ourperform Rating from William Blair - September 14 at 11:43 AM logoHead-To-Head Analysis: Marathon Patent Group (MARA) and Stericycle (SRCL) - September 13 at 10:34 PM logoComparing Stericycle (SRCL) & Sharps Compliance Corp (SMED) - September 13 at 2:54 PM logoStericycle, Inc. (SRCL) Receives Consensus Recommendation of "Hold" from Brokerages - September 13 at 9:34 AM logo$897.97 Million in Sales Expected for Stericycle, Inc. (SRCL) This Quarter - September 12 at 8:52 AM logoStericycle (SRCL) and Sharps Compliance Corp (SMED) Financial Comparison - September 9 at 10:30 PM logoHead-To-Head Review: Heritage-Crystal Clean (HCCI) versus Stericycle (SRCL) - September 9 at 10:24 AM logoStericycle (SRCL) Down 13.3% Since Earnings Report: Can It Rebound? - Nasdaq - September 6 at 8:32 AM logoFinancial Comparison: Heritage-Crystal Clean (HCCI) & Stericycle (SRCL) - September 5 at 2:16 PM logoStericycle (SRCL) Down 13.3% Since Earnings Report: Can It Rebound? - September 5 at 8:41 AM logoIs Stericycle (SRCL) a Great Stock for Value Investors? - Nasdaq - August 24 at 1:13 PM logoStericycle, Inc. (SRCL) Expected to Announce Quarterly Sales of $897.97 Million - August 24 at 8:06 AM logo$1.15 Earnings Per Share Expected for Stericycle, Inc. (SRCL) This Quarter - August 22 at 10:24 PM logoThe Surprising Secret To Stericycle's Digital Transformation - August 22 at 6:55 AM logoStericycle, Inc. (SRCL) Receives Consensus Rating of "Hold" from Analysts - August 19 at 9:02 AM logoSTERICYCLE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn ... - August 19 at 7:45 AM logoSTERICYCLE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn ... - August 19 at 7:45 AM logoSTERICYCLE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Stericycle, Inc. - SRCL - August 19 at 7:45 AM logoSTERICYCLE INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Stericycle, Inc. - SRCL - August 19 at 7:45 AM logoContrasting Stericycle (SRCL) & Perma-Fix Environmental Services (PESI) - August 17 at 12:26 PM logoStericycle, Inc. – Value Analysis (NASDAQ:SRCL) : August 17, 2017 - August 17 at 7:53 AM logoSTERICYCLE INVESTIGATION INITIATED by Former Louisiana ... - Business Wire (press release) - August 13 at 6:31 AM logoJefferies Group LLC Analysts Give Stericycle, Inc. (NASDAQ:SRCL) a $108.00 Price Target - August 12 at 4:32 PM logoSee what the IHS Markit Score report has to say about Stericycle Inc. - August 12 at 8:02 AM logo[$$] Firm Discloses SEC Subpoena in Bribery Probe - August 12 at 8:02 AM logoSTERICYCLE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Stericycle, Inc. – SRCL - August 12 at 8:02 AM logoStericycle subpoenaed in federal anti-corruption probes - MarketWatch - August 10 at 8:11 AM logoThe Law Offices of Nicholas Koluncich III, LLC Announces Lawsuit against Stericycle, Inc. (SRCL) and Investigation ... - Business Wire (press release) - August 10 at 8:11 AM logoStericycle subpoenaed in federal anti-corruption probes - August 10 at 8:11 AM logoBarclays PLC Reiterates Overweight Rating for Stericycle, Inc. (SRCL) - August 9 at 3:58 PM logoFinancial Contrast: Covanta Holding Corporation (CVA) and Stericycle (NASDAQ:SRCL) - August 9 at 12:24 PM logoA Bitter Pill: Recalled Pharmaceutical Units Increase 444 Percent in Q2 - August 9 at 7:47 AM logoStericycle Was the S&P 500’s Top Gainer on August 3 - August 8 at 7:06 AM logoThe Law Offices of Nicholas Koluncich III, LLC Announces Lawsuit against Stericycle, Inc. (SRCL) and Investigation of Stericycle Board – Shareholders Encouraged to Contact Us - August 8 at 7:06 AM logoQ3 2017 Earnings Forecast for Stericycle, Inc. (NASDAQ:SRCL) Issued By Jefferies Group - August 7 at 7:34 AM logoAnalysts Set Expectations for Stericycle, Inc.'s Q3 2017 Earnings (NASDAQ:SRCL) - August 7 at 7:18 AM



Stericycle (SRCL) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.